Craft

GTx

Revenue

$4.3 M

FY, 2021

GTx Summary

Company Summary

Overview
GTx is a pharmaceutical company and developer of drugs that utilize hormonal pathways. It focuses on androgen receptor modulators, also referred to as SARMs, to treat a number of diseases, including breast cancer, stress urinary incontinence, and Duchenne muscular dystrophy.
Type
Subsidiary
Status
Closed
Founded
1997
HQ
Memphis, TN, US | view all locations
Website
http://www.gtxinc.com/
Cybersecurity rating
Sectors

Key People

  • Marc S. Hanover

    Marc S. Hanover, President and Chief Operating Officer

LocationsView all

1 location detected

  • Memphis, TN HQ

    United States

    175 Toyota Plaza #100

GTx Financials

Summary Financials

Revenue (Q3, 2022)
$382.0K
Net income (Q3, 2022)
($11.1M)
EBIT (Q3, 2022)
($11.3M)

Footer menu